PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy

by Sobhani, Navid, Generali, Daniele, Roviello, Giandomenico
Published in EBioMedicine (2017)

Bevacizumab in small cell lung cancer

by Roviello, Giandomenico, Sobhani, Navid, Generali, Daniele
Published in Ann Transl Med (2017)

Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma

by Sobhani, Navid, Corona, Silvia P., Zanconati, Fabrizio, Generali, Daniele
Published in Genes Cancer (2017)

MR1-Restricted T Cells in Cancer Immunotherapy

by Flores-Villanueva, Pedro, Sobhani, Navid, Wang, Xu, Li, Yong
Published in Cancers (Basel) (2020)

Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives?

by Sobhani, Navid, Generali, Daniele, Zanconati, Fabrizio, Bortul, Marina, Scaggiante, Bruna
Published in World J Clin Oncol (2018)

Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer

by Sobhani, Navid, Generali, Daniele, Zanconati, Fabrizio, Bortul, Marina, Scaggiante, Bruna
Published in World J Clin Oncol (2018)

Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancer

by Sobhani, Navid, Sirico, Marianna, Generali, Daniele, Zanconati, Fabrizio, Scaggiante, Bruna
Published in World J Clin Oncol (2020)

Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer

by Sobhani, Navid, Fassl, Anne, Mondani, Giuseppina, Generali, Daniele, Otto, Tobias
Published in Cells (2021)

The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments

by Sobhani, Navid, Fan, Chunmei, O. Flores-Villanueva, Pedro, Generali, Daniele, Li, Yong
Published in Int J Mol Sci (2020)

Mutant p53 as an Antigen in Cancer Immunotherapy

by Sobhani, Navid, D’Angelo, Alberto, Wang, Xu, Young, Ken H., Generali, Daniele, Li, Yong
Published in Int J Mol Sci (2020)

CTLA-4 in Regulatory T Cells for Cancer Immunotherapy

by Sobhani, Navid, Tardiel-Cyril, Dana Rae, Davtyan, Aram, Generali, Daniele, Roudi, Raheleh, Li, Yong
Published in Cancers (Basel) (2021)

Advances in anti-BRAF therapies for lung cancer

by Roviello, Giandomenico, D’Angelo, Alberto, Sirico, Marianna, Pittacolo, Matteo, Conter, Felipe Umpierre, Sobhani, Navid
Published in Invest New Drugs (2021)

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer

by Sobhani, Navid, Ianza, Anna, D’Angelo, Alberto, Roviello, Giandomenico, Giudici, Fabiola, Bortul, Marina, Zanconati, Fabrizio, Bottin, Cristina, Generali, Daniele
Published in Cells (2018)

AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption

by Sobhani, Navid, Neeli, Praveen Kumar, D’Angelo, Alberto, Pittacolo, Matteo, Sirico, Marianna, Galli, Ilaria Camilla, Roviello, Giandomenico, Nesi, Gabriella
Published in Int J Mol Sci (2021)

Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer

by Sobhani, Navid, D’Angelo, Alberto, Pittacolo, Matteo, Roviello, Giandomenico, Miccoli, Anna, Corona, Silvia Paola, Bernocchi, Ottavia, Generali, Daniele, Otto, Tobias
Published in Cells (2019)

Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies

by D’Angelo, Alberto, Sobhani, Navid, Chapman, Robert, Bagby, Stefan, Bortoletti, Carlotta, Traversini, Mirko, Ferrari, Katia, Voltolini, Luca, Darlow, Jacob, Roviello, Giandomenico
Published in Cancers (Basel) (2020)

Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma

by D’Angelo, Alberto, Sobhani, Navid, Roviello, Giandomenico, Bagby, Stefan, Bonazza, Deborah, Bottin, Cristina, Giudici, Fabiola, Zanconati, Fabrizio, De Manzini, Nicolo, Guglielmi, Alessandra, Generali, Daniele
Published in PLoS One (2019)

Early Changes of the Standardized Uptake Values (SUV(max)) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer

by Sirico, Marianna, Bernocchi, Ottavia, Sobhani, Navid, Giudici, Fabiola, Corona, Silvia P., Vernieri, Claudio, Nichetti, Federico, Cappelletti, Maria Rosa, Milani, Manuela, Strina, Carla, Cervoni, Valeria, Barbieri, Giuseppina, Ziglioli, Nicoletta, Dester, Martina, Bianchi, Giulia Valeria, De Braud, Filippo, Generali, Daniele
Published in Cancers (Basel) (2020)

Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study

by Schettini, Francesco, Sobhani, Navid, Ianza, Anna, Triulzi, Tiziana, Molteni, Alfredo, Lazzari, Maria Chiara, Strina, Carla, Milani, Manuela, Corona, Silvia Paola, Sirico, Marianna, Bernocchi, Ottavia, Giudici, Fabiola, Cappelletti, Maria Rosaria, Ciruelos, Eva, Jerusalem, Guy, Loi, Sherine, Fox, Stephen B., Generali, Daniele
Published in Breast Cancer Res Treat (2020)